Pharmacyclics
A DOL Labor Condition Application record spanning FY2023–2023. Review the filing volume, DOL certification record, and offered-wage context below.
- DOL LCA filings
- 3
- DOL-certified
- 100%
- Median offered wage
- $152,333
North Chicago, IL NAICS: 3254
The DOL filing record for Pharmacyclics
U.S. Department of Labor's OFLC discloses 3 Labor Condition Application filings naming Pharmacyclics from FY2023 through FY2023, drawn directly from DOL's quarterly public disclosure releases. An LCA is the wage-and-working-conditions attestation an employer files with DOL before petitioning USCIS for an H-1B worker: it is a filing record, not a USCIS approval, a job offer, or a confirmed hire, and the count reflects filings, not people, since an employer sponsoring the same role at more than one worksite, or refiling across fiscal years, is counted once per filing. See filing history · Recent LCAs
Approvals and denials for Pharmacyclics
Separate from the DOL filing record above, U.S. Citizenship and Immigration Services adjudicated 94 H-1B petitions naming Pharmacyclics through FY2020, and approved nearly every one of them: 97.9% approved (92 approvals, 2 denials). A DOL certification is the labor-condition step filed before a petition; this USCIS figure is the actual adjudicated outcome, and the two rates commonly differ.
The verdict
Pharmacyclics is listed in 3 DOL LCA filings, more filings than 67% of employer filers in this extract. DOL certified 100% of those LCAs; the median listed offered wage is $152,333. This is not a USCIS approval, hiring, or sponsorship ranking.
- 3
- DOL LCA filings, FY2023–FY2023
- 100%
- DOL-certified
- $152,333
- median offered wage
- Top 33%
- of employer filers by volume
According to U.S. Department of Labor OFLC LCA disclosure files (FY2023–FY2023). Based in North Chicago, IL.
Pharmacyclics vs all U.S. employer filers by LCA volume
Where this employer's disclosed Labor Condition Application count sits among every tracked employer filer (inventory signal, not a sponsorship ranking)
3 52221st of 122824 higher than 70,603 of 122,824 employer filers
Employer filers, banded by disclosed H-1B LCA filing count
Each bar is a band; taller bars hold more employer filers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source U.S. Department of Labor OFLC · FY2023–FY2023
LCA filing shape · Pharmacyclics
Derived from this employer's disclosed LCAs on file (FY2023–FY2023), title mix and worksite counties, not national boilerplate. LCA filings do not establish USCIS outcomes or confirmed hiring.
Offered-wage span on file: $117,000–$170,000 .
Title concentration
- Associate Director, Market & Patient Activation Analytics 2 · 66.7% · $170,000
- Full-Stack Developer, Web & Mobile 1 · 33.3% · $117,000
Worksite counties
- SAN MATEO, CA 2 · 66.7%
- DALLAS, TX 1 · 33.3%
DOL LCA release change
What changed between the two LCA fiscal years
- Pharmacyclics disclosed zero H-1B LCA filings in FY2025 after 3 in FY2024.
Thin filer, multi-state worksites
Only 3 LCAs, but worksites already span 2 states (CA, TX). HQ North Chicago, IL · DOL cert 100%.
Geographic Distribution
Where Pharmacyclics places H-1B workers across the United States
Recent LCA Filings
Latest H-1B labor condition applications filed by Pharmacyclics
| Job Title | Location | Salary | Status | Year |
|---|---|---|---|---|
| Full-Stack Developer, Web & Mobile | Irving, TX | $117,000 | Certified | FY2023 |
| Associate Director, Market & Patient Activation Analytics | South San Francisco, CA | $170,000 | Certified | FY2023 |
| Associate Director, Market & Patient Activation Analytics | South San Francisco, CA | $170,000 | Certified | FY2023 |
Nationwide peers near Pharmacyclics's 3-LCA band
Cross-state DOL neighbors for Pharmacyclics - LCA filing-count and offered-wage axes, outside IL.
Similar avg offered wage
Cross-state employer filers with a comparable average listed offered wage ($152,333 here).
Disclaimer: Informational only, not professional advice.
Read with Pharmacyclics
ABS(total_petitions) peers first, then a LARGEST-distance pole and a stamp-branched drill, not a fixed Related strip. This page stamps TRACE-BOOK · CERT-LOCK · WAGE-PREMIUM.
ABS(total_petitions) peer at 3 LCAs (Δ 0 heavier vs Pharmacyclics); CERT-SOFT · WAGE-BELOW vs this page's TRACE-BOOK · CERT-LOCK · WAGE-PREMIUM.
ABS(total_petitions) peer at 3 LCAs (Δ 0 heavier vs Pharmacyclics); CERT-LOCK · WAGE-BELOW vs this page's TRACE-BOOK · CERT-LOCK · WAGE-PREMIUM.
ABS(total_petitions) peer at 3 LCAs (Δ 0 heavier vs Pharmacyclics); CERT-LOCK · WAGE-PAR vs this page's TRACE-BOOK · CERT-LOCK · WAGE-PREMIUM.
ABS(total_petitions) peer at 3 LCAs (Δ 0 heavier vs Pharmacyclics); CERT-LOCK · WAGE-BELOW vs this page's TRACE-BOOK · CERT-LOCK · WAGE-PREMIUM.
IL pole at 11,656 LCAs stamps MEGA-BOOK · CERT-CLEAN, farthest ABS(total_petitions) contrast from Pharmacyclics's TRACE-BOOK.
Open the IL state board after the ABS peers. Pharmacyclics stamps TRACE-BOOK · CERT-LOCK inside that worksite mix.
Pharmacyclics's WAGE-PREMIUM offered-wage posture needs occupation/state context, not a shared guide card.
What to do with this profile
Use the DOL LCA record for Pharmacyclics to compare filing volume and offered wages, not USCIS outcomes.
- Pharmacyclics filed 3 LCAs in the indexed extract (100% certified in-file). That volume ranks higher than 67% of employer filers.
- Compare offered wages and certification rates against 6 same-state filers on the chart above. Jump to compare
- See how other employers in IL rank on LCA filing volume this vintage. IL filers
- Read what an LCA filing records versus a USCIS petition approval. LCA vs petition
DOL disclosure data only. Not legal advice, sponsorship guarantees, or visa eligibility.
Every figure on PlainVisa is rendered directly from federal source data, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error. Data current as of 2026-09-09.